Skip To Main Content
Andreas Bartholdy on Muck Rack

Andreas Bartholdy

As seen in: BMJ Open, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andreas

Contact Andreas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Long-term adherence to glucose-lowering therapy and cardiovascular risk in type 2 diabetes: a nationwide cohort study

|
By Andreas Bartholdy, Simon Rasmussen Verified, Marta Guasch-Ferré
| The Lancet Verified
Keywords Type 2 diabetes Medication adherence Cardiovascular disease Epidemiology Evidence before this study We searched PubMed for peer-reviewed human studies published from database inception to November 1, 2025. The literature search was conducted on November 1, 2025, using the terms “type 2 diabetes”, “medication adherence”, “proportion of days covered”, “medication possession ratio”, and “group-based trajectory modelling”, without language restrictions. We identified 96 relevant studies.
Open in Who Shared Issue with article?

Danish Pathology Life Course (PATHOLIFE) cohort: a register based cohort extending upon a national tissue biobank

|
By Laust Hvas Mortensen, Samir Bhatt, Pernille Yde Nielsen, Andreas Bartholdy
| BMJ Open Verified
Strengths and limitations Through linking the DNPR with the entire Danish population alive on 1 January 1986, or born after this date, the PATHOLIFE cohort can be a useful tool in clinical epidemiological research on patients with histological and cytological features from tissues. The PATHOLIFE cohort includes many health related events and outcomes, which can facilitate identification and analysis of clinically interesting patient groups.
Open in Who Shared View Duplicates (2) Issue with article?
See all 2 articles